Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense
NCT01489033
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Rhinoconjunctivitis
Interventions
BIOLOGICAL:
Subcutaneous immunotherapy with Phleum pratense pollen extract
Sponsor
Roxall Medicina España S.A